Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Combining machine learning with cell engineering, scientists can design ‘living medicines’ that precisely target tumors
A genomic study has uncovered molecular changes in tumors that may lead to dramatic and long-lasting responses to cancer therapy.
Longer delays were associated with worsening risk of death.
Antibody-drug conjugates are targeted agents that package cancer drugs for special delivery to tumor cells.
He battled Stage IV pancreatic cancer for 18 months.
There’s a gender gap too. Doctors are more likely to discuss potential problems with men than with women.
The report found U.S. cancer patients spent $5.6 billion in out-of-pocket costs for cancer treatment in 2018.
Diagnosed 10 months ago, the 32-year-old political strategist is receiving targeted therapy.
Jamil Rivers, 42, is the board president of METAvivor, a nonprofit breast cancer organization. She is living with metastatic breast cancer.
Radiation and chemotherapy treatment were associated with higher rates of mental and physical issues lasting up to a decade.
Researchers reveal how intercellular chambers where tumor cells share growth signals can drive cancer spread.
The report highlights how cancer research is extending and improving lives and includes a special feature on COVID-19 and cancer challenges.
The honeybee’s sting contains a compound that kills hard-to-treat breast cancer cells quickly.
The antibody-drug conjugate nearly doubled survival time for people with triple-negative breast cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.